Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALIMTA Plus Carboplatin in NSCLC
NCT00051493Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Eli Lilly and Company. Started Apr 2002; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00051493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00051493.